Anticytokine autoantibodies in a patient with a heterozygous NFKB2 mutation

[...]she developed recurrent deep-seated pyogenic bacterial infections throughout childhood and early teenage years, which included a deep abscess in the left proximal tibia complicated by septic arthritis of the hip, septic arthritis of the right knee, and osteomyelitis of the left pubic ramus, and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of allergy and clinical immunology 2018-04, Vol.141 (4), p.1479-1482.e6
Hauptverfasser: Ramakrishnan, Kesava A., Rae, William, Barcenas-Morales, Gabriela, Gao, Yifang, Pengelly, Reuben J., Patel, Sanjay V., Kumararatne, Dinakantha S., Ennis, Sarah, Döffinger, Rainer, Faust, Saul N., Williams, Anthony P.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1482.e6
container_issue 4
container_start_page 1479
container_title Journal of allergy and clinical immunology
container_volume 141
creator Ramakrishnan, Kesava A.
Rae, William
Barcenas-Morales, Gabriela
Gao, Yifang
Pengelly, Reuben J.
Patel, Sanjay V.
Kumararatne, Dinakantha S.
Ennis, Sarah
Döffinger, Rainer
Faust, Saul N.
Williams, Anthony P.
description [...]she developed recurrent deep-seated pyogenic bacterial infections throughout childhood and early teenage years, which included a deep abscess in the left proximal tibia complicated by septic arthritis of the hip, septic arthritis of the right knee, and osteomyelitis of the left pubic ramus, and prepatellar bursitis and bacterial cellulitis of the right thigh with associated bacteremia. Because of the autosomal-dominant pattern of inheritance of CVID within the family, genetic investigation was performed. Whole-exome sequencing and Sanger sequencing confirmation identified a heterozygous NFKB2 NM_001077494.2 c.2557C>T:p.Arg853Ter variant that resulted in a truncated NF-κB2 p100 subunit to be present in the I.1 and II.2 (Fig 1; see Figs E2 and E3 in this article's Online Repository at www.jacionline.org). Because of disease severity discordance between I.1 and II.2, further immunological investigations were performed. The development and pattern of ACAAs, as well as clinical feature of alopecia and trachyonychia, observed in II.2 is reminiscent of that of autoimmune polyendocrinopathy-candidasis-ectodermal dysplasia (APECED) and thymoma patients in whom there is impairment of thymic medullary function, resulting in autoimmunity (Fig 2, B).2 Correct function of the NF-κB2 pathway is required to establish the thymic medullary compartment and correctly regulate AIRE expression.3 NFKB2Lym1−/− knockout mice also show significant impairment of medullary thymic epithelial cell maturation and AIRE expression, leading to the development of autoantibodies.4 Therefore, we hypothesize that errant thymic function in patients with heterozygous NFKB2 mutations may led to ACAAs and the broad organ-specific autoimmunity, including the cutaneous manifestations, which are present in this patient group.1 ACAAs have been reported in other primary immunodeficiencies, including patients with biallelic hypofunctional RAG variants in whom neutralizing anti–IFN-α, IFN-ω, and IL-12 autoantibodies were associated with increased susceptibility to viral infections.5 IFN-α, IFN-ω, and IL-12p40 ACAAs were present in II.2, and we may postulate that it is similarly also underlying medullary thymic epithelial cell impairment in patients with hypofunctional RAG genes, AIRE deficiency, and thymoma that leads to the development of this specific ACAA pattern.6 However, the precise role of neutralizing ACAAs in health and disease remains elusive with the presence of neutralizing type 1 IFN AC
doi_str_mv 10.1016/j.jaci.2017.11.014
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1975594591</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0091674917318821</els_id><sourcerecordid>1975594591</sourcerecordid><originalsourceid>FETCH-LOGICAL-c428t-ff290c818d5375cdfb14a73d30e1a1407c47f7d1b8b64f354e437914abcc794f3</originalsourceid><addsrcrecordid>eNp9kMFO3DAQhq0KVBbKC_SAInHpJcHj2HEs9QKoQAWCSzlbjjMpTnfjre202j49Xi30wIHTaEbf_2v0EfIZaAUUmrOxGo11FaMgK4CKAv9AFkCVLJuWiT2yoFRB2UiuDshhjCPNe92qj-SAKcYEbcWC3J5PydlN8r_chIWZkzf50PneYSzcVJhibZLDKRV_XXrK6xMmDP7f5qefY3F_dXvBitWcMuOnT2R_MMuIxy_ziDxefftxeVPePVx_vzy_Ky1nbSqHgSlqW2h7UUth-6EDbmTd1xTBAKfScjnIHrq2a_hQC468lioznbVS5csR-bLrXQf_e8aY9MpFi8ulmTB_pUFJIRQXCjJ6-gYd_Rym_J1mlEGjatGITLEdZYOPMeCg18GtTNhooHqrWo96q1pvVWsAnVXn0MlL9dytsP8feXWbga87ALOLPw6DjjabtNi7gDbp3rv3-p8B4s2OdA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2021693565</pqid></control><display><type>article</type><title>Anticytokine autoantibodies in a patient with a heterozygous NFKB2 mutation</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Ramakrishnan, Kesava A. ; Rae, William ; Barcenas-Morales, Gabriela ; Gao, Yifang ; Pengelly, Reuben J. ; Patel, Sanjay V. ; Kumararatne, Dinakantha S. ; Ennis, Sarah ; Döffinger, Rainer ; Faust, Saul N. ; Williams, Anthony P.</creator><creatorcontrib>Ramakrishnan, Kesava A. ; Rae, William ; Barcenas-Morales, Gabriela ; Gao, Yifang ; Pengelly, Reuben J. ; Patel, Sanjay V. ; Kumararatne, Dinakantha S. ; Ennis, Sarah ; Döffinger, Rainer ; Faust, Saul N. ; Williams, Anthony P.</creatorcontrib><description>[...]she developed recurrent deep-seated pyogenic bacterial infections throughout childhood and early teenage years, which included a deep abscess in the left proximal tibia complicated by septic arthritis of the hip, septic arthritis of the right knee, and osteomyelitis of the left pubic ramus, and prepatellar bursitis and bacterial cellulitis of the right thigh with associated bacteremia. Because of the autosomal-dominant pattern of inheritance of CVID within the family, genetic investigation was performed. Whole-exome sequencing and Sanger sequencing confirmation identified a heterozygous NFKB2 NM_001077494.2 c.2557C&gt;T:p.Arg853Ter variant that resulted in a truncated NF-κB2 p100 subunit to be present in the I.1 and II.2 (Fig 1; see Figs E2 and E3 in this article's Online Repository at www.jacionline.org). Because of disease severity discordance between I.1 and II.2, further immunological investigations were performed. The development and pattern of ACAAs, as well as clinical feature of alopecia and trachyonychia, observed in II.2 is reminiscent of that of autoimmune polyendocrinopathy-candidasis-ectodermal dysplasia (APECED) and thymoma patients in whom there is impairment of thymic medullary function, resulting in autoimmunity (Fig 2, B).2 Correct function of the NF-κB2 pathway is required to establish the thymic medullary compartment and correctly regulate AIRE expression.3 NFKB2Lym1−/− knockout mice also show significant impairment of medullary thymic epithelial cell maturation and AIRE expression, leading to the development of autoantibodies.4 Therefore, we hypothesize that errant thymic function in patients with heterozygous NFKB2 mutations may led to ACAAs and the broad organ-specific autoimmunity, including the cutaneous manifestations, which are present in this patient group.1 ACAAs have been reported in other primary immunodeficiencies, including patients with biallelic hypofunctional RAG variants in whom neutralizing anti–IFN-α, IFN-ω, and IL-12 autoantibodies were associated with increased susceptibility to viral infections.5 IFN-α, IFN-ω, and IL-12p40 ACAAs were present in II.2, and we may postulate that it is similarly also underlying medullary thymic epithelial cell impairment in patients with hypofunctional RAG genes, AIRE deficiency, and thymoma that leads to the development of this specific ACAA pattern.6 However, the precise role of neutralizing ACAAs in health and disease remains elusive with the presence of neutralizing type 1 IFN ACAAs potentially conveying a beneficial protective counterbalance in those at high risk of, or suffering, autoimmune diseases.7,8 Following rituximab treatment we observed a clinical improvement with a reduction in infections despite not all ACAAs measured displaying a significant reduction (Fig E4).</description><identifier>ISSN: 0091-6749</identifier><identifier>EISSN: 1097-6825</identifier><identifier>DOI: 10.1016/j.jaci.2017.11.014</identifier><identifier>PMID: 29225085</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Arthritis ; Autoantibodies ; Autoantibodies - immunology ; Bacterial infections ; Baldness ; CD4-Positive T-Lymphocytes - immunology ; Child, Preschool ; Cytokines - immunology ; Female ; Genotype &amp; phenotype ; Haemophilus ; Heterozygote ; Humans ; Immunologic Memory - immunology ; Immunology ; Infections ; Lymphocytes ; Lymphoma ; Male ; Monoclonal antibodies ; Mutation ; Mutation - genetics ; NF-kappa B p52 Subunit - genetics ; NF-kappa B p52 Subunit - immunology ; Patients ; Pedigree ; Primary immunodeficiencies ; Proteins ; Targeted cancer therapy ; Tetanus ; Viral infections</subject><ispartof>Journal of allergy and clinical immunology, 2018-04, Vol.141 (4), p.1479-1482.e6</ispartof><rights>2017 American Academy of Allergy, Asthma &amp; Immunology</rights><rights>Copyright Elsevier Science Ltd. Apr 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c428t-ff290c818d5375cdfb14a73d30e1a1407c47f7d1b8b64f354e437914abcc794f3</citedby><cites>FETCH-LOGICAL-c428t-ff290c818d5375cdfb14a73d30e1a1407c47f7d1b8b64f354e437914abcc794f3</cites><orcidid>0000-0003-3410-7642 ; 0000-0003-0095-2514</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0091674917318821$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29225085$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ramakrishnan, Kesava A.</creatorcontrib><creatorcontrib>Rae, William</creatorcontrib><creatorcontrib>Barcenas-Morales, Gabriela</creatorcontrib><creatorcontrib>Gao, Yifang</creatorcontrib><creatorcontrib>Pengelly, Reuben J.</creatorcontrib><creatorcontrib>Patel, Sanjay V.</creatorcontrib><creatorcontrib>Kumararatne, Dinakantha S.</creatorcontrib><creatorcontrib>Ennis, Sarah</creatorcontrib><creatorcontrib>Döffinger, Rainer</creatorcontrib><creatorcontrib>Faust, Saul N.</creatorcontrib><creatorcontrib>Williams, Anthony P.</creatorcontrib><title>Anticytokine autoantibodies in a patient with a heterozygous NFKB2 mutation</title><title>Journal of allergy and clinical immunology</title><addtitle>J Allergy Clin Immunol</addtitle><description>[...]she developed recurrent deep-seated pyogenic bacterial infections throughout childhood and early teenage years, which included a deep abscess in the left proximal tibia complicated by septic arthritis of the hip, septic arthritis of the right knee, and osteomyelitis of the left pubic ramus, and prepatellar bursitis and bacterial cellulitis of the right thigh with associated bacteremia. Because of the autosomal-dominant pattern of inheritance of CVID within the family, genetic investigation was performed. Whole-exome sequencing and Sanger sequencing confirmation identified a heterozygous NFKB2 NM_001077494.2 c.2557C&gt;T:p.Arg853Ter variant that resulted in a truncated NF-κB2 p100 subunit to be present in the I.1 and II.2 (Fig 1; see Figs E2 and E3 in this article's Online Repository at www.jacionline.org). Because of disease severity discordance between I.1 and II.2, further immunological investigations were performed. The development and pattern of ACAAs, as well as clinical feature of alopecia and trachyonychia, observed in II.2 is reminiscent of that of autoimmune polyendocrinopathy-candidasis-ectodermal dysplasia (APECED) and thymoma patients in whom there is impairment of thymic medullary function, resulting in autoimmunity (Fig 2, B).2 Correct function of the NF-κB2 pathway is required to establish the thymic medullary compartment and correctly regulate AIRE expression.3 NFKB2Lym1−/− knockout mice also show significant impairment of medullary thymic epithelial cell maturation and AIRE expression, leading to the development of autoantibodies.4 Therefore, we hypothesize that errant thymic function in patients with heterozygous NFKB2 mutations may led to ACAAs and the broad organ-specific autoimmunity, including the cutaneous manifestations, which are present in this patient group.1 ACAAs have been reported in other primary immunodeficiencies, including patients with biallelic hypofunctional RAG variants in whom neutralizing anti–IFN-α, IFN-ω, and IL-12 autoantibodies were associated with increased susceptibility to viral infections.5 IFN-α, IFN-ω, and IL-12p40 ACAAs were present in II.2, and we may postulate that it is similarly also underlying medullary thymic epithelial cell impairment in patients with hypofunctional RAG genes, AIRE deficiency, and thymoma that leads to the development of this specific ACAA pattern.6 However, the precise role of neutralizing ACAAs in health and disease remains elusive with the presence of neutralizing type 1 IFN ACAAs potentially conveying a beneficial protective counterbalance in those at high risk of, or suffering, autoimmune diseases.7,8 Following rituximab treatment we observed a clinical improvement with a reduction in infections despite not all ACAAs measured displaying a significant reduction (Fig E4).</description><subject>Arthritis</subject><subject>Autoantibodies</subject><subject>Autoantibodies - immunology</subject><subject>Bacterial infections</subject><subject>Baldness</subject><subject>CD4-Positive T-Lymphocytes - immunology</subject><subject>Child, Preschool</subject><subject>Cytokines - immunology</subject><subject>Female</subject><subject>Genotype &amp; phenotype</subject><subject>Haemophilus</subject><subject>Heterozygote</subject><subject>Humans</subject><subject>Immunologic Memory - immunology</subject><subject>Immunology</subject><subject>Infections</subject><subject>Lymphocytes</subject><subject>Lymphoma</subject><subject>Male</subject><subject>Monoclonal antibodies</subject><subject>Mutation</subject><subject>Mutation - genetics</subject><subject>NF-kappa B p52 Subunit - genetics</subject><subject>NF-kappa B p52 Subunit - immunology</subject><subject>Patients</subject><subject>Pedigree</subject><subject>Primary immunodeficiencies</subject><subject>Proteins</subject><subject>Targeted cancer therapy</subject><subject>Tetanus</subject><subject>Viral infections</subject><issn>0091-6749</issn><issn>1097-6825</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMFO3DAQhq0KVBbKC_SAInHpJcHj2HEs9QKoQAWCSzlbjjMpTnfjre202j49Xi30wIHTaEbf_2v0EfIZaAUUmrOxGo11FaMgK4CKAv9AFkCVLJuWiT2yoFRB2UiuDshhjCPNe92qj-SAKcYEbcWC3J5PydlN8r_chIWZkzf50PneYSzcVJhibZLDKRV_XXrK6xMmDP7f5qefY3F_dXvBitWcMuOnT2R_MMuIxy_ziDxefftxeVPePVx_vzy_Ky1nbSqHgSlqW2h7UUth-6EDbmTd1xTBAKfScjnIHrq2a_hQC468lioznbVS5csR-bLrXQf_e8aY9MpFi8ulmTB_pUFJIRQXCjJ6-gYd_Rym_J1mlEGjatGITLEdZYOPMeCg18GtTNhooHqrWo96q1pvVWsAnVXn0MlL9dytsP8feXWbga87ALOLPw6DjjabtNi7gDbp3rv3-p8B4s2OdA</recordid><startdate>201804</startdate><enddate>201804</enddate><creator>Ramakrishnan, Kesava A.</creator><creator>Rae, William</creator><creator>Barcenas-Morales, Gabriela</creator><creator>Gao, Yifang</creator><creator>Pengelly, Reuben J.</creator><creator>Patel, Sanjay V.</creator><creator>Kumararatne, Dinakantha S.</creator><creator>Ennis, Sarah</creator><creator>Döffinger, Rainer</creator><creator>Faust, Saul N.</creator><creator>Williams, Anthony P.</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7SS</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3410-7642</orcidid><orcidid>https://orcid.org/0000-0003-0095-2514</orcidid></search><sort><creationdate>201804</creationdate><title>Anticytokine autoantibodies in a patient with a heterozygous NFKB2 mutation</title><author>Ramakrishnan, Kesava A. ; Rae, William ; Barcenas-Morales, Gabriela ; Gao, Yifang ; Pengelly, Reuben J. ; Patel, Sanjay V. ; Kumararatne, Dinakantha S. ; Ennis, Sarah ; Döffinger, Rainer ; Faust, Saul N. ; Williams, Anthony P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c428t-ff290c818d5375cdfb14a73d30e1a1407c47f7d1b8b64f354e437914abcc794f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Arthritis</topic><topic>Autoantibodies</topic><topic>Autoantibodies - immunology</topic><topic>Bacterial infections</topic><topic>Baldness</topic><topic>CD4-Positive T-Lymphocytes - immunology</topic><topic>Child, Preschool</topic><topic>Cytokines - immunology</topic><topic>Female</topic><topic>Genotype &amp; phenotype</topic><topic>Haemophilus</topic><topic>Heterozygote</topic><topic>Humans</topic><topic>Immunologic Memory - immunology</topic><topic>Immunology</topic><topic>Infections</topic><topic>Lymphocytes</topic><topic>Lymphoma</topic><topic>Male</topic><topic>Monoclonal antibodies</topic><topic>Mutation</topic><topic>Mutation - genetics</topic><topic>NF-kappa B p52 Subunit - genetics</topic><topic>NF-kappa B p52 Subunit - immunology</topic><topic>Patients</topic><topic>Pedigree</topic><topic>Primary immunodeficiencies</topic><topic>Proteins</topic><topic>Targeted cancer therapy</topic><topic>Tetanus</topic><topic>Viral infections</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ramakrishnan, Kesava A.</creatorcontrib><creatorcontrib>Rae, William</creatorcontrib><creatorcontrib>Barcenas-Morales, Gabriela</creatorcontrib><creatorcontrib>Gao, Yifang</creatorcontrib><creatorcontrib>Pengelly, Reuben J.</creatorcontrib><creatorcontrib>Patel, Sanjay V.</creatorcontrib><creatorcontrib>Kumararatne, Dinakantha S.</creatorcontrib><creatorcontrib>Ennis, Sarah</creatorcontrib><creatorcontrib>Döffinger, Rainer</creatorcontrib><creatorcontrib>Faust, Saul N.</creatorcontrib><creatorcontrib>Williams, Anthony P.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of allergy and clinical immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ramakrishnan, Kesava A.</au><au>Rae, William</au><au>Barcenas-Morales, Gabriela</au><au>Gao, Yifang</au><au>Pengelly, Reuben J.</au><au>Patel, Sanjay V.</au><au>Kumararatne, Dinakantha S.</au><au>Ennis, Sarah</au><au>Döffinger, Rainer</au><au>Faust, Saul N.</au><au>Williams, Anthony P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Anticytokine autoantibodies in a patient with a heterozygous NFKB2 mutation</atitle><jtitle>Journal of allergy and clinical immunology</jtitle><addtitle>J Allergy Clin Immunol</addtitle><date>2018-04</date><risdate>2018</risdate><volume>141</volume><issue>4</issue><spage>1479</spage><epage>1482.e6</epage><pages>1479-1482.e6</pages><issn>0091-6749</issn><eissn>1097-6825</eissn><abstract>[...]she developed recurrent deep-seated pyogenic bacterial infections throughout childhood and early teenage years, which included a deep abscess in the left proximal tibia complicated by septic arthritis of the hip, septic arthritis of the right knee, and osteomyelitis of the left pubic ramus, and prepatellar bursitis and bacterial cellulitis of the right thigh with associated bacteremia. Because of the autosomal-dominant pattern of inheritance of CVID within the family, genetic investigation was performed. Whole-exome sequencing and Sanger sequencing confirmation identified a heterozygous NFKB2 NM_001077494.2 c.2557C&gt;T:p.Arg853Ter variant that resulted in a truncated NF-κB2 p100 subunit to be present in the I.1 and II.2 (Fig 1; see Figs E2 and E3 in this article's Online Repository at www.jacionline.org). Because of disease severity discordance between I.1 and II.2, further immunological investigations were performed. The development and pattern of ACAAs, as well as clinical feature of alopecia and trachyonychia, observed in II.2 is reminiscent of that of autoimmune polyendocrinopathy-candidasis-ectodermal dysplasia (APECED) and thymoma patients in whom there is impairment of thymic medullary function, resulting in autoimmunity (Fig 2, B).2 Correct function of the NF-κB2 pathway is required to establish the thymic medullary compartment and correctly regulate AIRE expression.3 NFKB2Lym1−/− knockout mice also show significant impairment of medullary thymic epithelial cell maturation and AIRE expression, leading to the development of autoantibodies.4 Therefore, we hypothesize that errant thymic function in patients with heterozygous NFKB2 mutations may led to ACAAs and the broad organ-specific autoimmunity, including the cutaneous manifestations, which are present in this patient group.1 ACAAs have been reported in other primary immunodeficiencies, including patients with biallelic hypofunctional RAG variants in whom neutralizing anti–IFN-α, IFN-ω, and IL-12 autoantibodies were associated with increased susceptibility to viral infections.5 IFN-α, IFN-ω, and IL-12p40 ACAAs were present in II.2, and we may postulate that it is similarly also underlying medullary thymic epithelial cell impairment in patients with hypofunctional RAG genes, AIRE deficiency, and thymoma that leads to the development of this specific ACAA pattern.6 However, the precise role of neutralizing ACAAs in health and disease remains elusive with the presence of neutralizing type 1 IFN ACAAs potentially conveying a beneficial protective counterbalance in those at high risk of, or suffering, autoimmune diseases.7,8 Following rituximab treatment we observed a clinical improvement with a reduction in infections despite not all ACAAs measured displaying a significant reduction (Fig E4).</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>29225085</pmid><doi>10.1016/j.jaci.2017.11.014</doi><orcidid>https://orcid.org/0000-0003-3410-7642</orcidid><orcidid>https://orcid.org/0000-0003-0095-2514</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0091-6749
ispartof Journal of allergy and clinical immunology, 2018-04, Vol.141 (4), p.1479-1482.e6
issn 0091-6749
1097-6825
language eng
recordid cdi_proquest_miscellaneous_1975594591
source MEDLINE; Elsevier ScienceDirect Journals
subjects Arthritis
Autoantibodies
Autoantibodies - immunology
Bacterial infections
Baldness
CD4-Positive T-Lymphocytes - immunology
Child, Preschool
Cytokines - immunology
Female
Genotype & phenotype
Haemophilus
Heterozygote
Humans
Immunologic Memory - immunology
Immunology
Infections
Lymphocytes
Lymphoma
Male
Monoclonal antibodies
Mutation
Mutation - genetics
NF-kappa B p52 Subunit - genetics
NF-kappa B p52 Subunit - immunology
Patients
Pedigree
Primary immunodeficiencies
Proteins
Targeted cancer therapy
Tetanus
Viral infections
title Anticytokine autoantibodies in a patient with a heterozygous NFKB2 mutation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T07%3A56%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Anticytokine%20autoantibodies%20in%20a%20patient%20with%20a%20heterozygous%20NFKB2%20mutation&rft.jtitle=Journal%20of%20allergy%20and%20clinical%20immunology&rft.au=Ramakrishnan,%20Kesava%20A.&rft.date=2018-04&rft.volume=141&rft.issue=4&rft.spage=1479&rft.epage=1482.e6&rft.pages=1479-1482.e6&rft.issn=0091-6749&rft.eissn=1097-6825&rft_id=info:doi/10.1016/j.jaci.2017.11.014&rft_dat=%3Cproquest_cross%3E1975594591%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2021693565&rft_id=info:pmid/29225085&rft_els_id=S0091674917318821&rfr_iscdi=true